Key statistics
As of last trade Alkermes Plc (8AK:MUN) traded at 26.20, -12.67% below its 52-week high of 30.00, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.20 |
---|---|
High | 26.20 |
Low | 26.20 |
Bid | 26.20 |
Offer | 26.40 |
Previous close | 26.00 |
Average volume | 29.63 |
---|---|
Shares outstanding | 164.67m |
Free float | 162.51m |
P/E (TTM) | 10.84 |
Market cap | 4.77bn USD |
EPS (TTM) | 2.67 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:01 BST.
More ▼
Press releases
- Alkermes to Host Investor Event to Review Orexin Portfolio Strategy
- Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
- Alkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference
- Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
- Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Alkermes Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 2
- Alkermes plc Reports Second Quarter 2024 Financial Results
- Alkermes to Report Second Quarter Financial Results on July 24, 2024
More ▼